INS and obesity disorder: Adiponectin, which is typically reduced in obesity, enhances insulin sensitivity, suppresses reactive oxygen species, and modulates anti-inflammatory pathways via AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) pathways [83,84].